COMPARISON OF IN VITRO DISSOLUTION AND IN VIVO BIOAVAILABILITY OF METHAQUALONE TABLETS IN HUMANSSTOLL RG; CHAO GC; HOYT HJ et al.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 9; PP. 1328-1329; BIBL. 10 REF.Article

GENERIC PROPOXYPHENE: NEED FOR CLINICAL BIOAVAILABILITY EVALUATION.DESANTE KA; STOLL RG; KAISER DG et al.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 12; PP. 1713-1716; BIBL. 11 REF.Article

CHLORPHENESIN CARBAMATE SERUM LEVELS DURING SUBCHRONIC ADMINISTRATION TO HUMAN (NORMAL) VOLUNTEERSSTOLL RG; DESANTE KA; NOVAK E et al.1974; J. CLIN. PHARMACOL.; U.S.A.; DA. 1974; VOL. 14; NO 10; PP. 520-524; BIBL. 5 REF.Article

INTERSUBJECT VARIATION OF WARFARIN BINDING TO PROTEIN IN SERUM OF NORMAL SUBJECTS.YACOBI A; STOLL RG; DISANTO AR et al.1976; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1976; VOL. 14; NO 4; PP. 743-746; BIBL. 6 REF.Article

IN VITRO AND IN VIVO AVAILABILITY OF SOME COMMERCIAL PREDNISOLONE TABLETSSULLIVAN TJ; STOLL RG; SAKMAR E et al.1974; J. PHARMACOKINET. BIOPHARMACEUT.; G.B.; DA. 1974; VOL. 2; NO 1; PP. 29-41; BIBL. 8REF.Article

CLINICAL BIOAVAILABILITY OF NITROFURANTOIN. A CASE OF BIOINEQUIVALENCEDISANTO AR; CHODOS DJ; PHILLIPS JP et al.1976; INTERNATION. J. CLIN. PHARMACOL. BIOPHARM.; GERM.; DA. 1976; VOL. 13; NO 3; PP. 220-227; BIBL. 9 REF.Article

A SENSITIVE AND SPECIFIC METHOD FOR THE ANALYSIS OF PARA-AMINOSALICYLIC ACID AND ITS N-ACETYL METABOLITE IN HUMAN PLASMA = UNE METHODE SENSIBLE ET SPECIFIQUE POUR L'ANALYSE DE L'ACIDE P-AMINOSALICYLIQUE ET DE SES METABOLITES N-ACETYLES DANS LE PLASMA HUMAINSTOLL RG; HOLMES PD; ROTH SB et al.1972; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1972; VOL. 4; NO 2; PP. 327-338; BIBL. 7 REF.Serial Issue

ELIMINATION OF HIGH MOLECULAR WEIGHT HYDROXYETHYLSTARCH IN RATSHULSE JD; STOLL RG; AVRAHAM YACOBI et al.1980; REV. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1980; VOL. 29; NO 1; PP. 149-158; BIBL. 8 REF.Article

COMPARISON OF THE IN VITRO AND IN VIVO RELEASE OF DIGOXIN FROM FOUR DIFFERENT SOFT GELATIN CAPSULE FORMULATIONSWAGNER JG; STOLL RG; WEIDLER DJ et al.1979; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1979; VOL. 7; NO 2; PP. 147-158; BIBL. 13 REF.Article

NITROGLYCERIN COMPATIBILITY WITH INTRAVENOUS FLUID FILTERS, CONTAINERS AND ADMINISTRATION SETSBAASKE DM; AMANN AH; WAGENKNECHT DM et al.1980; AMER. J. HOSP. PHARM.; USA; DA. 1980; VOL. 37; NO 2; PP. 201-205; BIBL. 12 REF.Article

THE ASSESSMENT OF THE INTRASUBJECT VARIABILITY IN DIGOXIN ABSORPTION IN MAN FROM TWO ORAL DOSAGE FORMSYACOBI A; STOLL RG; CHAO GC et al.1981; J. CLIN. PHARMACOL.; ISSN 0091-2700; USA; DA. 1981; VOL. 21; NO 7; PP. 301-310; BIBL. 15 REF.Article

EVALUATION OF SUSTAINED-ACTION CHLORPHENIRAMINE-PSEUDOEPHEDRINE DOSAGE FORM IN HUMANSYACOBI A; STOLL RG; CHAO GC et al.1980; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1980; VOL. 69; NO 9; PP. 1077-1081; BIBL. 14 REF.Article

INFLUENCE OF KAOLIN. PECTIN SUSPENSION ON DIGOXIN BIOAVAILABILITY.ALBERT KS; AYRES JW; DISANTO AR et al.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 11; PP. 1582-1586; BIBL. 4 REF.Article